Arcoma AB Cash Flow-to-Debt Ratio
Arcoma AB cash flow-to-debt ratio. Arcoma AB (ARCOMA) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of Skr68.00K could theoretically repay 0% of its total liabilities (Skr26.30 Million) in one year. Check Arcoma AB (ARCOMA) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Arcoma AB (2012–2025)
Cash flow-to-debt ratio of Arcoma AB from 2012 to 2025. Historical debt coverage capacity for Arcoma AB across 14 annual periods. Check Arcoma AB (ARCOMA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Arcoma AB Cash Flow-to-Debt Ratio by Year (2012–2025)
Arcoma AB cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Arcoma AB. For the full cash flow conversion analysis, see Arcoma AB operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.85x | Skr18.72 Million | Skr21.92 Million | ▼ -4.3% |
| 2024 | 0.89x | Skr18.84 Million | Skr21.13 Million | ▲ +55.0% |
| 2023 | 0.58x | Skr19.16 Million | Skr33.30 Million | ▲ +17602.3% |
| 2022 | 0.00x | Skr-179.00K | Skr54.46 Million | ▲ +94.0% |
| 2021 | -0.05x | Skr-1.93 Million | Skr35.23 Million | ▼ -136.4% |
| 2020 | 0.15x | Skr6.85 Million | Skr45.50 Million | ▼ -48.3% |
| 2019 | 0.29x | Skr11.10 Million | Skr38.14 Million | ▲ +23981.4% |
| 2018 | 0.00x | Skr45.00K | Skr37.24 Million | ▲ +100.4% |
| 2017 | -0.33x | Skr-8.91 Million | Skr27.28 Million | ▼ -137.3% |
| 2016 | -0.14x | Skr-4.67 Million | Skr33.90 Million | ▲ +4.5% |
| 2015 | -0.14x | Skr-4.95 Million | Skr34.34 Million | ▼ -552.4% |
| 2014 | -0.02x | Skr-828.00K | Skr37.48 Million | ▲ +89.1% |
| 2013 | -0.20x | Skr-11.82 Million | Skr58.35 Million | ▲ +12.5% |
| 2012 | -0.23x | Skr-10.27 Million | Skr44.35 Million | — |